Aluvia tablet approved in 19 African countries.
D000349:Africa; D019380:Anti-HIV Agents / Q000191:economics / Q000627:therapeutic use; D017277:Drug Approval; D004345:Drug Industry; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D061466:Lopinavir; D011744:Pyrimidinones / Q000191:economics / Q000627:therapeutic use; D019438:Ritonavir / Q000191:economics / Q000627:therapeutic use; D013607:Tablets
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D013607:Tablets; D061466:Lopinavir; D019438:Ritonavir